Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruggero De Maria

Showing results (1-10 of 236) with videos related to

Pageof 24
Sort By:
Cell Stem Cell|October 11, 2011
Not so lonely at the top for cancer stem cellsAnn Zeuner, Ruggero De Maria
Nature Immunology|February 27, 2001
Response to 'Thyrocytes - not innocent bystanders in autoimmune disease'Giorgio Stassi, Ruggero De Maria
Oncoscience|December 24, 2015
A predictive signature for therapy assignment and risk assessment in prostate cancerDésirée Bonci, Ruggero De Maria
Molecular & Cellular Oncology|September 22, 2016
miR-15/miR-16 loss, miR-21 upregulation, or deregulation of their target genes predicts poor prognosis in prostate cancer patientsDésirée Bonci, Ruggero De Maria
Nature Reviews. Immunology|March 27, 2002
Autoimmune thyroid disease: new models of cell death in autoimmunityGiorgio Stassi, Ruggero De Maria
Cancer Immunology, Immunotherapy : CII|August 9, 2014
Cancer stem cells: perspectives for therapeutic targetingCristina Maccalli, Ruggero De Maria
Critical Reviews in Oncology/Hematology|January 4, 2016
Hippo pathway and breast cancer stem cellsMarcello Maugeri-Saccà, Ruggero De Maria
Pharmacology & Therapeutics|January 7, 2018
The Hippo pathway in normal development and cancerMarcello Maugeri-Saccà, Ruggero De Maria
Annali Dell'Istituto Superiore Di Sanita|March 25, 2011
Translating basic research in cancer patient careMarcello Maugeri-Saccà, Ruggero De Maria
Endocrine-Related Cancer|September 26, 2009
MicroRNAs and prostate cancerValeria Coppola, Ruggero De Maria, Désirée Bonci
Pageof 24

Showing results (1-10 of 236) with videos related to

Sort By:
Pageof 24
Cell Stem Cell|October 11, 2011
Not so lonely at the top for cancer stem cellsAnn Zeuner, Ruggero De Maria
Nature Immunology|February 27, 2001
Response to 'Thyrocytes - not innocent bystanders in autoimmune disease'Giorgio Stassi, Ruggero De Maria
Oncoscience|December 24, 2015
A predictive signature for therapy assignment and risk assessment in prostate cancerDésirée Bonci, Ruggero De Maria
Molecular & Cellular Oncology|September 22, 2016
miR-15/miR-16 loss, miR-21 upregulation, or deregulation of their target genes predicts poor prognosis in prostate cancer patientsDésirée Bonci, Ruggero De Maria
Nature Reviews. Immunology|March 27, 2002
Autoimmune thyroid disease: new models of cell death in autoimmunityGiorgio Stassi, Ruggero De Maria
Cancer Immunology, Immunotherapy : CII|August 9, 2014
Cancer stem cells: perspectives for therapeutic targetingCristina Maccalli, Ruggero De Maria
Critical Reviews in Oncology/Hematology|January 4, 2016
Hippo pathway and breast cancer stem cellsMarcello Maugeri-Saccà, Ruggero De Maria
Pharmacology & Therapeutics|January 7, 2018
The Hippo pathway in normal development and cancerMarcello Maugeri-Saccà, Ruggero De Maria
Annali Dell'Istituto Superiore Di Sanita|March 25, 2011
Translating basic research in cancer patient careMarcello Maugeri-Saccà, Ruggero De Maria
Endocrine-Related Cancer|September 26, 2009
MicroRNAs and prostate cancerValeria Coppola, Ruggero De Maria, Désirée Bonci
Pageof 24